Komori
Ivy Cosmetics (4918) · InitiativeAdvancedLatest General Meetings of Shareholders (2026-06-04): "Restated"

Industrial Applications of Patented Technology

First written in FY2024. 2 of 4 entries say "Advanced", first in FY2025-H1. Latest entry: 2026-06-04.

4entries
3years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024AdvancedFY2025-H1 – FY20252024: 220242025: 120252026: 12026
Same theme, other companies
Creating new businesses through patent and technology licensingA theme 5 companies write about · 0 as a headwind · 5 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. 2026-06-04RestatedGeneral Meetings of Shareholders

    「We will also promote the generation of sales outside the door-to-door sales business, including overseas sales and the promotion of patent licensing.」

    The company continues its policy of using licenses for patented technology as a new source of revenue.
  2. FY2025AdvancedAnnual report

    「As our research institute has conducted research on skin, we have been able to obtain valuable patents. The claims cover not only cosmetics but also pharmaceuticals, and we intend to provide licenses to pharmaceutical companies and others going forward, making this a new source of revenue.」

    The company has stated a policy of using its patented technology by providing licenses to pharmaceutical companies as a new source of revenue.
  3. FY2025-H1AdvancedAnnual report

    「In addition to applying the invention to our own products, we intend to promote its use by society through licensing agreements with pharmaceutical manufacturers and other companies.」

    Following the patent grant for an Nrf2 activator, the company has specified a policy of applying it to its own products and promoting its industrial and social use through licensing agreements with pharmaceutical manufacturers and other companies.
  4. FY2024First statedAnnual report

    「We will also promote the industrial use of our patented technology.」

    Separately from continuing research and development and the acquisition of patents, the company has stated for the first time a policy of applying its patented technology in industry.
Moved together

"Continued Research into Skin Whitening, Anti-Aging, New Materials and DDS" moved the same way as this thread, in the same document, in 2 of its 4 moves.

222222★123456
  1. ★This thread
  2. 1Continued Research into Skin Whitening, Anti-Aging, New Materials and DDS2×
  3. 2Developing Core Sales Staff and Strengthening the Training System2×
  4. 3Expansion of Distributors and Sales Offices and Support for Sales Organizations2×
  5. 4Strengthening the earnings base through lower manufacturing costs, minimized fixed costs, and effective use of assets2×
  6. 5Raising Working Capital through Bank-Guaranteed Privately Placed Bonds2×
  7. 6Improving Deteriorated KPIs and Operating Cash Flow2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Ivy Cosmetics yet. It last moved in the General Meetings of Shareholders of 2026-06-04: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Industrial Applications of Patented Technology | IVY COSMETICS CORPORATION (4918) | Komori